UBS ASSET MANAGEMENT AMERICAS LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 5 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$6,513,885,000
+14.2%
10,500,0000.0%0.00%0.0%
Q1 2020$5,701,605,000
-33.2%
10,500,0000.0%0.00%
-20.0%
Q4 2019$8,531,250,000
+12.3%
10,500,0000.0%0.01%0.0%
Q3 2019$7,593,600,000
-33.6%
10,500,0000.0%0.01%
-37.5%
Q2 2019$11,434,500,000
+6.5%
10,500,0000.0%0.01%0.0%
Q1 2019$10,735,200,000
-8.1%
10,500,0000.0%0.01%
-20.0%
Q4 2018$11,677,785,000
-25.2%
10,500,0000.0%0.01%
-16.7%
Q3 2018$15,604,575,000
-8.0%
10,500,0000.0%0.01%
-7.7%
Q2 2018$16,969,471,000
+24.4%
10,500,0000.0%0.01%
+18.2%
Q1 2018$13,640,235,000
-2.5%
10,500,000
+5.0%
0.01%
-8.3%
Q4 2017$13,987,001,000
-14.2%
10,000,0000.0%0.01%
-20.0%
Q3 2017$16,296,500,000
-21.6%
10,000,0000.0%0.02%
-25.0%
Q2 2017$20,797,200,000
+24.2%
10,000,000
+11.1%
0.02%
+17.6%
Q1 2017$16,750,080,000
+116992.5%
9,000,000
+12.5%
0.02%
+6.2%
Q4 2016$14,305,000
-9.9%
8,000,000
+14.3%
0.02%
-5.9%
Q3 2016$15,873,000
-5.5%
7,000,000
-22.2%
0.02%
-10.5%
Q2 2016$16,795,000
-12.6%
9,000,000
-25.0%
0.02%
-13.6%
Q1 2016$19,225,000
+0.4%
12,000,000
+9.1%
0.02%0.0%
Q4 2015$19,154,00011,000,0000.02%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 17,500,000$31,512,0006.26%
ANGELO GORDON & CO., L.P. 10,000,000$17,913,0001.32%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 12,000,000$21,586,000,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 8,750,000$15,714,0000.20%
LAZARD ASSET MANAGEMENT LLC 9,570,000$17,190,0000.04%
Citadel Advisors 16,800,000$30,248,0000.03%
UBS ASSET MANAGEMENT AMERICAS LLC 8,000,000$14,305,0000.02%
ClearBridge Investments 3,000,000$5,503,0000.01%
JPMORGAN CHASE & CO 1,880,000$3,449,0000.00%
View complete list of LEXICON PHARMACEUTICALS INC shareholders